Menu
← Oncology Approval Tracker
FDA DECISION ·
Lapatinib (Tykerb first generic)
lapatinib · Natco Pharma
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic Tykerb for use with capecitabine after specified prior therapy in HER2-positive advanced or metastatic breast cancer, or with letrozole in selected postmenopausal patients with hormone receptor-positive, HER2-positive metastatic disease.
LAMPGEN ANALYSIS
Why it matters
Added a generic source of the HER2-directed oral agent used in established combinations.
What research teams should watch
Check the intended partner drug and interaction and cardiac monitoring plans before substitution.
PRIMARY RECORDS